Overview

Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED)

Status:
Completed

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

Summary

Verify if the quantitative parameters of the eosinophils activation and phagocyte system function show a predictive value for clinical response and prognostic in patients with persistent asthma treated with montelukast

Phase:

Phase 4

Details

Lead Sponsor:

University of Brasilia

Treatments:

Montelukast